Abstract: A method is proposed for carrying out quality control on an analytical process which belongs to a group of related analytical processes that can be executed in at least one analytical device and includes a respective chain of sub-processes. The method includes fundamental chemical and/or physical underlying sub-processes being stored for the group in a first database. Further, at least one section of the chain of the analytical process is emulated by the specification of one of the underlying sub-processes for each sub-process in a section of the chain, using at least one control parameter and at least one corresponding threshold value. Finally, measured values are determined for the control parameters for at least one run of the analytical process and the measured values are compared with the corresponding threshold values for the quality control procedure.

Abstract: A method and a system are for supporting therapy planning when creating a training program. The method involves a capability profile for a patient and also a first and a second database being provided. The first database contains a plurality of skills and an allocation of minimum prerequisites for capabilities required for the respective skills. The second database contains a plurality of skills with expert rules relating to the selection of exercises and/or of capabilities to be treated and also their order and/or weighting for the purpose of acquiring the respective skills taking into account existing capabilities and capability deficits.

Abstract: In a method and a network for evaluating medical data in a clinical study, biochips containing patient samples with multiple biomolecular markers are tested in a number of point of care test devices respectively at point of care sites. Each test of each biochip sample produces a diagnostic result, which is entered into the electronic patient record for the patient who produced the sample. A follow-up examination is subsequently conducted for each patient, and the results of the follow-up examination are also entered into that patient's electronic patient record. The follow-up results indicate whether the diagnostic test result was a false positive, a false negative or correct. The follow-up data and the original diagnostic results from all point of care sites are electronically transmitted to a remote server, which has access to an expert system which uses the test results and the follow-up data to automatically devise a measurement protocol for a selected pathology.

Abstract: A broker service facilitates the provision of health-related information to an interested third party. The broker enters into an agreement with one or more health care institutions to obtain at least some access to health-related information stored on a server. In response to a request by the third party, the broker may construct a search filter to find relevant information stored on the server. The broker then may forward at least some of the results to the third party. The broker may install a plug-in software program on the server to facilitate access to the health-related information and/or limit the information based on local health care regulations.

Abstract: An electronic health card (EHC), system containing the EHC and a terminal, and method of promoting use of the EHC are provided. The EHC contains information that promotes the use of the EHC. This information may include personal information of the owner, authorization information that enables access to distributed sources of personal health records, and one or more health care benefits associated with the owner. The benefit may be selectable from individual incentives or predetermined bundles of incentives. The benefit may be conferred only if the owner uses the EHC when being provided with or when providing health care. Data communicated through contact or contactlessly between the EHC and terminal, and between the terminal and external databases, allows the owner to be provided with the benefit.

Abstract: A method is for verifying the feasibility of a medical study using acceptance criteria for patients. The method includes defining target criteria for the study. Based on the acceptance criteria, a patient collective including potential patients is selected from a database containing patient data of patients. The patient data of the patient collective are evaluated based on the target criteria. Finally, a measure for the feasibility of the study is established.

Abstract: A method is disclosed for carrying out quality control of medical data records collected from different but comparable patient collectives within the bounds of a medical plan. In the method, for each data record, a quality control parameter assigned thereto is determined in the same manner. Further, the quality control parameters are evaluated using comparison criteria.

Abstract: A method is for evaluating the quality of electronically stored, particularly medical, knowledge data. The knowledge data are stored in a database; quality data correlated with the knowledge data are stored in the database, and; when a user accesses the knowledge data, the quality data are automatically provided to the user.

Abstract: A method is disclosed for verifying whether an implementation rule assigned to a medical procedure has been observed. The method includes: data correlated with the procedure is automatically entered and stored in a data processing device; test criteria for the data, which are correlated with the implementation rule, are stored in a test system; the procedure is implemented; the test system reads out the data from the data processing device; and the test system evaluates the data based on the test criteria and determines to what degree the implementation rule has been observed.

Abstract: During a method for selecting a potential participant for a medical study on the basis of a selection criterion, patient data assigned to a patient are electronically stored. A secondary criterion is assigned to the selection criterion. The patient data are electronically evaluated on the basis of the secondary criterion. Based on this electronic evaluation, a measure for fulfilling the selection criterion is determined for the patient associated with the patient data. The patient is selected as a potential participant on the basis of this measure.

Abstract: A method is disclosed for performing a clinical study on a patient. The study-related or patient-related data is stored in a memory during the study. The memory is readable by a physician who is foreign to the study and is associated with the patient. An information system for a clinical study on a patient encompasses a memory for study-related or patient-related data, which is allocated to the patient, a data input device for storing data in the memory, and a data reading device for reading out the data from the memory. The data reading device is accessible to a physician who is foreign to the study and is associated with the patient.

Abstract: A method is disclosed for conducting a clinical study according to which an event occurs during the study that requires a collaboration of individuals responsible for the study. The method includes transmitting the event to a collaboration system. The collaboration system determines, based on parameters assigned to the event, a group of individuals responsible for the study required for the collaboration. The collaboration system provides a communications platform for the group. The group carries out the collaboration while using the communications platform. Finally, the collaboration system verifies the collaboration on the basis of predetermined verification criteria.

Abstract: A method for studying a biological sample in a biochip (“lab-on-a-chip”) is disclosed. In at least one embodiment of the method, a biological sample is introduced into the biochip, the sample is subjected to at least one preparation step and, at the end of a measurement cycle, the concentration of a particular analyte is measured. The concentration of a marker substance, which for example is a reaction substance involved in a preparation step, is furthermore measured. A corresponding biochip is further disclosed.

Abstract: A method is disclosed for selecting a participant in a medical project with selection criteria for patients. The method includes verifying patient data, that is contained in a data processing system and is associated with patients, regarding the selection criteria. The patient associated with the patient data is selected as a participant if the selection criteria are met.

Abstract: A method is for linking sets of data including medical therapeutic indications. According to the method, the respective set of data of a therapeutic indication is provided with at least one output while a reference regarding a therapeutic indication that follows in a treatment process is allocated to an output such that any link can be created between therapeutic indications which succeed each other in a meaningful manner in the treatment process.

Abstract: A quality control system in disease management services for the enlightenment, development and motivation of patients in conjunction with telemonitoring of critical body values and, resulting from this, early recognition of risk situations, wherein random generators are used to create a virtual patient from the admissible patient data, wherein a random selection is made from the available hardware components, and wherein, likewise randomly generated, a random event is selected from a list of possible events in the disease management process, the system reaction when this event is run through being assessed by an expert system by using the reference responses known to the system in order to trace errors.

Abstract: Quality control system in Disease Management Services involving education, development and motivation of patients suffering from widespread chronic diseases, such as diabetes, asthma or hypertension, possibly involving telemonitoring of critical body values and resultant early identification and avoidance of risk situations, where an automatic delivery monitoring facility is provided which monitors the receipt of all messages and information by the patients and, if appropriate, informs a control station in order to eliminate access problems.

Abstract: A method is proposed for carrying out quality control on an analytical process which belongs to a group of related analytical processes that can be executed in at least one analytical device and includes a respective chain of sub-processes. The method includes fundamental chemical and/or physical underlying sub-processes being stored for the group in a first database. Further, at least one section of the chain of the analytical process is emulated by the specification of one of the underlying sub-processes for each sub-process in a section of the chain, using at least one control parameter and at least one corresponding threshold value. Finally, measured values are determined for the control parameters for at least one run of the analytical process and the measured values are compared with the corresponding threshold values for the quality control procedure.

Abstract: A method is disclosed for transmitting data to an information indicator. A subset of data is indicated to a human user from a total set of data containing appliance data, the subset of data being ascertained centrally after configuration on the information indicator. In a further disclosed communication device, the information indicator for presenting the appliance data is coupled to a central processor for determining the subset of data from the total set of data containing the appliance data for at least one terminal whose input is connected to the central processor for providing the appliance data.

Abstract: A bio-molecular contrast agent (BMCA) is introduced into a biological organism such that the agent binds or reacts with target tissue within that organism. The BMCA is also signal-giving, allowing control of particle beam therapy by tracking the signal given by BMCA. The BMCA gives multiple signals which interact with different tissue elements in different ways. The variance in these signals is utilized to determine the constituency of the tissue either before and/or during therapy.